According to Chugai Pharmaceutical's latest financial reports the company has $4.59 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $3.84 B | -6.26% |
2021-12-31 | $4.10 B | 11.72% |
2020-12-31 | $3.67 B | 20.02% |
2019-12-31 | $3.05 B | 35.33% |
2018-12-31 | $2.26 B | 4.76% |
2017-12-31 | $2.15 B | 22.6% |
2016-12-31 | $1.75 B | -10.23% |
2015-12-31 | $1.96 B | 1.79% |
2014-12-31 | $1.92 B | -13.87% |
2013-12-31 | $2.23 B | -9.3% |
2012-12-31 | $2.46 B | 12.92% |
2011-12-31 | $2.18 B | 30.89% |
2010-12-31 | $1.66 B | -2.61% |
2009-12-31 | $1.71 B | 23.73% |
2008-12-31 | $1.38 B | 11.42% |
2007-12-31 | $1.24 B | -1.68% |
2006-12-31 | $1.26 B | 4.08% |
2005-12-31 | $1.21 B | 27.89% |
2004-12-31 | $0.94 B | 52.36% |
2003-12-31 | $0.62 B |